series-c-plus
Stage
1
Investors
About
TetraLogic Pharma develops antibody-drug conjugates and polymer-drug conjugates for targeted cancer therapies.
Explore TetraLogic Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.